Member Spotlight / News - September 5, 2024
Every month, EUCOPE spotlights a member company and the great work it’s doing to advance the life sciences industry and drive innovation to serve patients better. This September, we spoke with Mike Ryan, Manager, Europe, EVERSANA. Mike Ryan has worked across the life sciences and… read more
Member Spotlight / News - February 5, 2024
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Enrico Piccinini, Head of Europe & International Rare Diseases, Chiesi Global Rare Diseases Enrico… read more
Member Spotlight / News - September 20, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In September, we spoke with Francois Lontrade, Directeur General, Laboratoire Cevidra. Before joining Cevidra, Francois Lontrade gained 18 years’… read more
Member Spotlight - August 22, 2023
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In August, we spoke with Shekhar Natarajan, Vice President – EU Regulatory Affairs, Dyne Therapeutics. Shekhar Natarajan is Vice President-… read more
EUCOPE Resources / News - July 12, 2023
EUCOPE’S Sounds of Science Podcast – Episode 16 Rare Reflections: Impact of the OMP revision on rare disease companies in Europe On 26 April 2023, the European Commission published its long awaited proposal revising the foundational pharmaceutical legislation, including the Orphan Medicinal Products (OMP) Regulation…. read more
Events & Meetings / News / Press Releases - February 20, 2023
There is momentum for change. Join us to discuss how to make that change happen! The challenges we are facing today within rare diseases are complex and extensive. To understand and overcome these, we need to work together and share knowledge across countries, between expert… read more
EUCOPE Resources / News - December 21, 2022
Sounds of Science – Episode 11 2022 Year in Review: Our Policy team’s perspectives on the past year in EU Health and a look ahead to 2023 Throughout 2022, there have been successes, challenges, delays and change within the European pharmaceutical industry and we expect… read more
News / Partnerships / Press Releases - December 8, 2022
A new initiative to boost research and development into rare and paediatric diseases will launch today [Thursday 8 December] at the European Health Summit. The ‘Rare Disease Moonshot’ is a commitment and collaboration between seven organisations to break down the barriers to finding new treatments and cures… read more
Member Spotlight / News - November 30, 2022
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In October, we spoke with Óscar Perez, Chief Officer, Marketing, Pricing & Market Access and Business Development at Ferrer Internacional…. read more
EUCOPE Resources / Events & Meetings - October 3, 2022
On September 5, 2022, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and Bundesverband der Pharmazeutischen Industrie (BPI) organised an online event on the revision of the EU regulatory framework for orphan drugs and its impact on Germany. The upcoming revision was discussed together with patient… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information